![David Colpman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Colpman
Director/Board Member at
ELUTIA INC.
Net worth: 26 869 $ as of 2026-08-30
Profile
David Colpman is currently an Independent Director at Elutia, Inc. since 2022.
Holds director positions at HighCape Capital Acquisition Corp.
II and Oak Hill Bio Corp.
since 2022.
Member of the Royal Pharmaceutical Society of Great Britain.
Advisor at HighCape Partners Management LLC and Science Creates Ventures LLP.
Formerly Director at HRA Pharma Development SARL from 2016 to 2022.
Non-Executive Director at Organon R&D Finland Oy.
Independent Director at HighCape Capital Acquisition Corp.
from 2020 to 2021.
Independent Director at Orexo AB from 2015 to 2022.
Senior Vice President at Shire Plc from 2012 to 2014.
Principal at GlaxoWellcome from 1997 to 1999.
Principal at Purdue Pharma (Canada) in 2015.
Partner at Colpman Consulting Ltd. from 2014 to 2020.
Completed undergraduate degree at the University of Portsmouth in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELUTIA INC CLASS A 0.07% | 2026-06-10 | 31,098 ( 0.07% ) | 26 869 $ | 2026-08-30 |
David Colpman active positions
| Companies | Position | Start |
|---|---|---|
| ELUTIA INC. | Director/Board Member | 2022-10-19 |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Corporate Officer/Principal | - |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Director/Board Member | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Director/Board Member | 2022-02-28 |
HighCape Partners Management LLC
 HighCape Partners Management LLC Investment ManagersFinance HighCape Partners invests in companies located in the United States. The firm targets companies operating the fields of commercial and life sciences sectors. It provides financing for growth stage transactions. | Consultant / Advisor | - |
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Consultant / Advisor | - |
Former positions of David Colpman
| Companies | Position | End |
|---|---|---|
| OREXO AB | Director/Board Member | 2022-04-30 |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Director/Board Member | 2022-03-31 |
| HIGE CAPI | Director/Board Member | 2021-06-09 |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of David Colpman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Commercial Services |
GlaxoWellcome /Pharmocology Unit/
 GlaxoWellcome /Pharmocology Unit/ Miscellaneous Commercial ServicesCommercial Services Provides research and development services to the pharmaceutical industry | Commercial Services |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Health Technology |
HighCape Partners Management LLC
HighCape Partners Management LLC Investment ManagersFinance HighCape Partners invests in companies located in the United States. The firm targets companies operating the fields of commercial and life sciences sectors. It provides financing for growth stage transactions. | Finance |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Colpman Consulting Ltd.
 Colpman Consulting Ltd. Financial ConglomeratesFinance Provides financial advisory service | Finance |
Elutia, Inc.
 Elutia, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops customized tissue products | Health Technology |
HighCape Capital Acquisition Corp.
 HighCape Capital Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Science Creates Ventures
Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Finance |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Commercial Services |
- Stock Market
- Insiders
- David Colpman
